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The complem ent system may play an important 
role in the pathogenesis of certain skin diseases. 
including the vesiculobullous skin diseases (pem-
phigu., bull ous pemphigoid. cicatricial pem-
phigoid, dermatitis herpetiform is. and herpes 
gestat ionisl and cutaneous forms of lupus ery-
thematosus and "asculit i .. In t he present report. 
com plement studies in pemphigus. bullous pem-
phigoid, and herpes gestationis will be presented. 
In addi lion, recent evidence for i m rnune com plex 
formation in orne of these diseases will he summa-
ri zed. 
PDIPHIGl'; 
Pre,'i"us studies have establi hed that autoanti-
bodies a re present in the serum of patients with 
aCli,'e pemphigus using indirect immunofluores-
cenl IlF ) sta ining [1 - 1J. These antibodies react 
specifically with an inte rcellular substance (lCS ) 
of skin and mucosa. and the~' react precisely at the 
site of the primar,' histopathologic lesion. 
B.v direct IF staining. ICS deposition of IgG ha, 
been present in "inualJ,' all skin lesions tested to 
date [2- 41. Similar Cl depositiun ha, been demon-
strable ma inly in skin lesions lrom patients prior to 
initiation of corticosteroid therapy [5.6 J. Clq and 
C4 deposit ion. in addition to Cl . has also been 
demonstrated in ICS areas of early pemphigus 
lesions, sugge~ t i"e of classical pathway activation 
[7,8 J. 
Besides deposition of Clq, C4. and Cl. we ha,'e 
recentlv demon~trated similar ICS deposition of 
Factor ' B \81. In contrast to other complement 
components. properdin has been seen in on ly a few 
lesion. and then on'" around a few acantholnic 
cells. Factor B depos·ition. therefore. may besi be 
explained b,' the "C;lb feedback" mechanism fol-
lowing dassical pathwav acri'·ation. 
\\' e ha,'e also reporl ed t hat LOt al hemol,·tic 
complement was decreased in blister Iluids of 
pemphigus "ulgaris pat ient s when compared to 
serum complement le,'els [9J. Hemol.,·tic C1. C4. 
C2. C3. and C5. determined in serum and bli5ter 
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IF: immunoOuorescenl 
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fluids from two patients. were not measurab le in 
one blis ter fluid and were extremely low in the 
second . Factor B. measured immunochemically. 
was absen t from both of these blister fluids . 
Pemphigus blister Iluids al 0 have exhibited anti-
complementary activ it,' when tested with normal 
human serum [9.10]. Addition of one blister f1uid 
to normal human serum resulted in inhibition of 
hemolytic C1. C2. C3. and C5 <class ical pathwa,' ) 
and both C3 and Factor B conYersion. 
Complement acti,'at ion locall,·. therefore. ma,' 
be important in the pathogenesis of pemphigus. 
lin.Lot ·" PE\IPHIGOID 
Complement acti"ation also may be important 
in the pathogenesis of bullous pemphigoid, a dis-
ease characterized by subepidermal bulla forma -
tion and autoantibodies 10 the basement mem-
brane zone <BMZI as demonstrated by indirect IF 
staining [3.11.121. These antibodies also react 
precisel~' with their corre, ponding histopathologic 
site. which ma~' explain the su bepidermal location 
of the bulla. 
Direct ff staining of bullous pemphigoid lesions 
has consist ent Iy demon. trat ed B~l Z deposition of 
IgG and C3 in "irtuallv all skin specimens exam-
ined [4, 13J. Provost and Tomasi [141 first reported 
that factors associated with the alternative path-
way are present in bullous pemphigoid lesions. 
In this respect they reponed deposition of bot.h 
properdin and Factor B. in addi t ion to Clq. C4. and 
C3 deposition. Thev ha,'e recently extended these 
observations [15 J and we ha,'e been able to con-
firm thei r findings 116]. 
B" in dtro complement staining methods. we 
had - reponed that most serologically positi"e bul-
lous pemphigoid sera fix C3 to the BM Z [11 J. 
Recentlv we ha,'e extended those studies sho""ing 
that b~llous pemphigoid antibodies will fix Clq 
and C4 in addition to C3 [18J, findings which sug-
gest that these antibodies act.ivate the classical 
complemem pathway. 
Blister fluids of most serologically POsili"e bul-
lous pemphigoid patients have reduced levels of 
total hemolvtic complement when compared to 
serum levels and other se rum and blister f1uid 
p roteins [10,19 ]. Serologically negative cases. on 
the ot her hand. had blister fluid complement le"e ls 
approaching serum levels. V':it h the except ion of 
the twO terminal components. C and C9. individ-
ual complement components appear to be 
decreased in blister fluids with low LOtal comple-
ment levels [19]. C3 and Factor B conversion is 
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also readily a pparent in these blister fluids but not 
in serum. Heat-stable chemotactic activity has 
also been identified in bullous pemphigoid blister 
fluids [20 ]. 
As in pemphigus. local complement activa tion 
may be important in the pathogenesis of bull ous 
pemphigoid . 
IM!vI L·:-.iE COMPLE X STL"DIES 
Using sucrose density gradient ultracentrifuga -
tion methods and hemolytic complement assays. 
we found tha t the pemphigus bl ister fluid a nticom-
plementary activity had an S value of over 19 [21 ]. 
Significant anticomplementary acti\'ity was also 
present in 3 of 5 bullous pemphigoid blister f1uids 
tested by these same methods . This ac tivity was 
also present in the more rapidly sedimenting 
gradient frac tions. :\one of the cont ro l blister 
flu ids. including cant ha ridin-induced blisters. uc· 
tion-induced bliste rs. and blister fl uid from a few 
patients with other bullous diseases. conta ined 
such acti,·ity. 
Six of 10 pemphigus sera tested have also 
demonstrated similar anticomplementary acti,·ity. 
although in this case the sedimenta t ion va lues 
were between 12 and 19 [21 ]. Two of 5 bullous 
pemphigoid sera also contained some an ticomple-
ment ary activi ty whi ch corresponded in sedimen-
tation to the bl ist.er fl uid acti ,·i ty . Act ivity in the 
bl ister f1u ids was always grea ter t han in t he 
correspond ing sera. 
As with pemphigus blister flui d alone. add it ion 
of posi tive grad ient frac tions of both pemphigus 
and bullous pemph igoid b lister fl uids to fres h 
normal human serum res ul ted in consumpt ion of 
both hemolytic Cl and C3. When these posi t ive 
gradient fractions were added to guinea-pig serum 
geneti call~' defi cient in t he 4t h component of 
complement. no consumption of hemolyt ic C1 was 
noted . 
We have also recently developed a radioassay 
employing "'I-labeled Clq as described by :-.lydeg-
ger et a l [22 ]. After incubat ing tes t sera wit h 
[' ''I ]Clq, t he radioactivity present in a l.5'1f 
polyethylene glycol precipitate is counted and com-
pared to a standa rd curve prepared with hea t -
aggregated [gG. Of 110 serum sa mples fro m 31 
pat ients wi t h acti ve pemphigus tested thus fa r. 2.') 
samples from 10 patients showed a s ignifi cantly 
elevated binding of ['25I]Clq [23]. In contrast, sera 
from 30 norma l donors exhibited consi stentl~' low 
leve ls of Clq precipi tation. Studies of sera a nd 
blis ter flu ids from patients wi t h bullous pem-
ph igoid a re present ly in progress. 
HERPES GEST.~ T IOX lS 
An uncommon vesic ulob ullous dermato is of 
pregna ncy and the postpart um period. herpes 
gestat ionis has recently been added to the list of 
bullous skin diseases with specific immunopa tho-
logic find ings . IF studies of two such patients were 
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report.ed by Provost and Tomasi ]14 ]. One 
patient's skin lesion showed basement membrane 
deposition of C3, C5, and properdin without simi-
lar deposition of Clq and immunoglobulins . The 
second patient demonstrated only C3 deposition . 
BMZ antibodies were not present in the serum 01 
either patient. but a heat-labile humoral fac tor. 
capable of precipitating C3 on normal skin base· 
ment membrane, was present . The presence of thi" 
factor , t herefore , may be of so me value in the 
diagnosis of he rpes gestation is. 
A patient with herpes gestat ion is who had IF 
findings similar to those of bullous pemphigoid was 
recently described by Bushkell , J ordon. and Goltz 
]24 ]. This patien t had circul at ing IgG ant ibodies to 
the BMZ a nd deposi tion of IgG and Clq in skin 
lesions in addi t ion to properdin and C3 . Finding" 
in th is patient sugges t that he rpes ge tationis may 
be more closely rela ted to bullous pemphigoi d tha n 
origina lly suspected . 
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